Gritstone bio Inc.

11/10/2021 | Press release | Distributed by Public on 11/10/2021 06:09

Gritstone Announces Positive Preclinical Data in Non-Human Primate Challenge Study with Second-Generation COVID-19 Vaccine Against SARS-CoV-2